Loader
File - The exterior of an AstraZeneca office is shown in South San Francisco, Calif., Tuesday, 30 September 2025.

Video. AstraZeneca quarterly net profit rises 2% on strong cancer drug sales

Updated:

Strong cancer drug sales lifted Anglo-Swedish pharmaceutical giant AstraZeneca’s second-quarter earnings above expectations, helping the company maintain its 2026 outlook.

Read full article
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT